Cited by 212Hepatitis B Virus StudiesHepatitis C virus researchHealth Promotion and Cardiovascular Prevention

The DOI matches its Crossref record; 44 of the 49 references it cites were found in a registry or an index.

Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement

Open access

US Preventive Services Task Force, Krist, Alex H., Davidson, Karina W., Mangione, Carol M., Barry, Michael J., Cabana, Michael, Caughey, Aaron B., Donahue, Katrina, Doubeni, Chyke A., Epling, John W., Kubik, Martha, Ogedegbe, Gbenga, Owens, Douglas K., Pbert, Lori, Silverstein, Michael, Simon, Melissa A., Tseng, Chien-Wen, Wong, John B.·2020·JAMA

DOI 10.1001/jama.2020.22980

Open this paper in CoChat — free account Open PDF

Abstract

Importance: An estimated 862 000 persons in the US are living with chronic infection with hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or greater, such as countries in Africa and Asia, the Pacific Islands, and parts of South America, often become infected at birth and account for up to 95% of newly reported chronic infections in the US. Other high-prevalence populations include persons who inject drugs; men who have sex with men; persons with HIV infection; and sex partners, needle-sharing contacts, and household contacts of persons with chronic HBV infection. Up to 60% of HBV-infected persons are unaware of their infection, and many remain asymptomatic until onset of cirrhosis or end-stage liver disease. Objective: To update its 2014 recommendation, the USPSTF commissioned a review of new randomized clinical trials and cohort studies published from 2014 to August 2019 that evaluated the benefits and harms of screening and antiviral therapy for preventing intermediate outcomes or health outcomes and the association between improvements in intermediate outcomes and health outcomes. New key questions focused on the yield of alternative HBV screening strategies and the accuracy of tools to identify persons at increased risk. Population: This recommendation statement applies to asymptomatic, nonpregnant adolescents and adults at increased risk for HBV infection, including those who were vaccinated before being screened for HBV infection. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for HBV infection in adolescents and adults at increased risk for infection has moderate net benefit. Recommendation: The USPSTF recommends screening for HBV infection in adolescents and adults at increased risk for infection. (B recommendation).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2020.22980

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Centers for Disease Control and Prevention
Branum, A. (2007) · Sage eBooks · doi:10.4135/9781412952644.n74 · Cited by 6,434
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Schweitzer, A., Horn, J., Mikolajczyk, R., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,747
Sexually transmitted diseases treatment guidelines (2015)
Workowski, K., & BOLAN, G. A. (2015) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2015.24.51-56 · Cited by 2,684
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Jarlais, D. C. D., Horyniak, D., & Degenhardt, L. J. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,266
Sexually Transmitted Diseases Treatment Guidelines 2002
(2002) · PsycEXTRA Dataset · doi:10.1037/e548482006-001 · Cited by 1,238
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Ghany, M. G., Morgan, T. R. M., & Panel, A. H. C. G. (2019) · Hepatology · doi:10.1002/hep.31060 · Cited by 991
The natural history of chronic hepatitis B virus infection #
McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.22898 · Cited by 879
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection #
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 818
Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Schillie, S. F., Wester, C., Osborne, M. C., Wesolowski, L. G., & Ryerson, A. B. (2020) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6902a1 · Cited by 565
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016
Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2018) · Hepatology · doi:10.1002/hep.30297 · Cited by 487
Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.
Moyer, V. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-5-201309030-00672 · Cited by 475
Toward a more accurate estimate of the prevalence of hepatitis C in the United States
Edlin, B. R., Eckhardt, B. J., Shu, M. A., Holmberg, S. D., & Swan, T. (2015) · Hepatology · doi:10.1002/hep.27978 · Cited by 437
Risk Factors for Perinatal Transmission of Hepatitis C Virus (HCV) and the Natural History of HCV Infection Acquired in Infancy
Mast, E. E., Hwang, L., Seto, D. S. Y., Nolte, F. S., Nainan, O. V., Wurtzel, H. L., & Alter, M. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/497701 · Cited by 393
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Chou, R., & Wasson, N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00005 · Cited by 372
Rising mortality associated with hepatitis C virus in the United States, 2003–2013
Ly, K. N., Hughes, E. M., Jiles, R. B., & Holmberg, S. D. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw111 · Cited by 358
Hepatitis B and human immunodeficiency virus coinfection #
Thio, C. L. (2009) · Hepatology · doi:10.1002/hep.22883 · Cited by 333
Screening for Hepatitis C Virus Infection in Adolescents and Adults
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M. D., Caughey, A. B., Donahue, K. E., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.1123 · Cited by 306
ACG Clinical Guideline: Liver Disease and Pregnancy
Tran, T. T., Ahn, J. C., & Reau, N. S. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.430 · Cited by 305
Hepatology
Schenker, S., Perkins, H. S., & Sorrell, M. F. (2006) · Hepatology · doi:10.1002/(issn)1527-3350 · Cited by 262
Why we should routinely screen Asian American adults for hepatitis B
Lin, S., Chang, E. T., & So, S. K. (2007) · Hepatology · doi:10.1002/hep.21784 · Cited by 231
Screening for HIV Infection
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M. D., Caughey, A. B., Curry, S. J., Doubeni, C. A., Epling, J. W., et al. (2019) · JAMA · doi:10.1001/jama.2019.6587 · Cited by 221
Vital Signs:Newly Reported Acute and Chronic Hepatitis C Cases ― United States, 2009–2018
Ryerson, A. B., Schillie, S. F., Barker, L. K., Kupronis, B. A., & Wester, C. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6914a2 · Cited by 165
Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention
Abara, W. E., Qaseem, A., Schillie, S. F., McMahon, B. J., & Harris, A. M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1106 · Cited by 150
Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014
Ly, K. N., Jiles, R. B., Teshale, E. H., Foster, M. A., Pesano, R. L., & Holmberg, S. D. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2350 · Cited by 148
Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016
Patel, E. U., Thio, C. L., Boon, D., Thomas, D. L., & Tobian, A. A. R. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz001 · Cited by 147
Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission — United States and Kentucky, 2011–2014
Koneru, A., Nelson, N. P., Hariri, S., Canary, L., Sanders, K. J., Maxwell, J. F., Huang, X., Leake, J. A. D., Ward, J. W., & Vellozzi, C. J. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6528a2 · Cited by 138
Chronic Hepatitis B Prevalence Among Foreign‐Born and U.S.‐Born Adults in the United States, 1999‐2016
Le, M. H., Yeo, Y. H., Cheung, R. C., Henry, L. L., Lok, A. S.-F., & Nguyen, M. H. (2019) · Hepatology · doi:10.1002/hep.30831 · Cited by 125
Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: U.S. Preventive Services Task Force Recommendation Statement
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-1018 · Cited by 111
Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States
Kim, H.-S., Rotundo, L., Yang, J. D., Kim, D., Kothari, N., Feurdean, M., Ruhl, C. E., & Ünalp–Arida, A. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12735 · Cited by 86
Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States
Barocas, J. A., Tasillo, A., Yazdi, G. E., Wang, J., Vellozzi, C. J., Hariri, S., Isenhour, C. J., Randall, L. M., Ward, J. W., Mermin, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy098 · Cited by 72
Screening for Hepatitis B Virus Infection in Pregnant Women
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M. D., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2019) · JAMA · doi:10.1001/jama.2019.9365 · Cited by 68
Screening for Hepatitis C Virus Infection in Adolescents and Adults
Chou, R., Dana, T., Fu, R., Zakher, B., Wagner, J., Ramirez, S., Grusing, S., & Jou, J. H. (2020) · JAMA · doi:10.1001/jama.2019.20788 · Cited by 67
Screening for Hepatitis B Virus Infection in Adolescents and Adults: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation
Chou, R., Dana, T., Bougatsos, C., Blazina, I., Khangura, J., & Zakher, B. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2837 · Cited by 55
Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: U.S. Preventive Services Task Force Recommendation Statement
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-1965 · Cited by 53
Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010
Rosenberg, E. S., Hall, E. W., Sullivan, P. S., Sanchez, T., Workowski, K., Ward, J. W., & Holtzman, D. J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix202 · Cited by 51
Screening for Hepatitis B Virus Infection in Pregnancy: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00011 · Cited by 47
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings
Spradling, P. R., Xing, J., Rupp, L. B., Moorman, A. C., Gordon, S. C., Teshale, E., Lu, M., Boscarino, J. A., Trinacty, C. M., Schmidt, M. A., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw516 · Cited by 45
Prevalence of Hepatitis B Virus Infection Among US Adults Aged 20–59 Years With a History of Injection Drug Use: National Health and Nutrition Examination Survey, 2001–2016
Shing, J. Z., Ly, K. N., Xing, J., Teshale, E. H., & Jiles, R. B. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz669 · Cited by 38
Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations
Turner, B. J., Rochat, A., Lill, S., Bobadilla, R., Hernández, L., Choi, A. N., & Guerrero, J. A. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3573 · Cited by 33
A Structural Competency Curriculum for Primary Care Providers to Address the Opioid Use Disorder, HIV, and Hepatitis C Syndemic
Bagchi, A. D. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00210 · Cited by 17
Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults
Chou, R., Blazina, I., Bougatsos, C., Holmes, R. S., Selph, S., Grusing, S., & Jou, J. H. (2020) · JAMA · doi:10.1001/jama.2020.19750 · Cited by 10
Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Systematic Review to Update the 2004 U.S. Preventive Services Task Force Recommendation
Chou, R., Dana, T., Bougatsos, C., Blazina, I., Zakher, B., & Khangura, J. (2014) · Cited by 9

Flagged first, then by citations

5 of the 49 references couldn’t be matched to a known paper.

Sorted by citations

Cancer Statistics, 2021
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore
Wong, J., Goh, Q. Y., Tan, Z., Lie, S. A., Tay, Y. C., Ng, S. Y., & Soh, C. R. (2020) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01620-9 · Cited by 731
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Schillie, S. F., Wester, C., Osborne, M. C., Wesolowski, L. G., & Ryerson, A. B. (2020) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6902a1 · Cited by 565
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
Conners, E. E., Panagiotakopoulos, L., Hofmeister, M. G., Spradling, P. R., Hagan, L. M., Harris, A. M., Rogers-Brown, J. S., Wester, C. W., Nelson, N. P., Contributors, et al. (2023) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7201a1 · Cited by 310

See all 212

Authors: US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., Kubik, M., Ogedegbe, G., Owens, D. K., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C.-W., & Wong, J. B.
Affiliations: Virginia Commonwealth University (US)
Northwell Health (US)
Harvard University (US)
Oregon Health & Science University (US)
University of North Carolina at Chapel Hill (US)
Mayo Clinic (US)
George Mason University (US)
New York University (US)
University of Massachusetts Chan Medical School (US)
Boston University (US)
Northwestern University (US)
University of Hawaiʻi at Mānoa (US)
Tufts University (US)
Corresponding author: Krist, Alex H.
ORCID: Krist, Alex H.
Davidson, Karina W.
Mangione, Carol M.
Barry, Michael J.
Cabana, Michael
Caughey, Aaron B.
Donahue, Katrina
Doubeni, Chyke A.
Epling, John W.
Kubik, Martha
Ogedegbe, Gbenga
Pbert, Lori
Silverstein, Michael
Simon, Melissa A.
Tseng, Chien-Wen
Wong, John B.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2020-12-15
Volume: 324
Issue: 23
Pages: 2415
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2020.22980
OpenAlex: W3010174353
Cited by: 212
References: 49
Citations by year: 2026: 13 · 2025: 11 · 2024: 23 · 2023: 35 · 2022: 38 · 2021: 55 · 2020: 37
FWCI: 29.57
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
eScholarship@UMassChan (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords: hepatitis B virus, hepatitis B screening, chronic hepatitis B, adolescents, adults, vulnerable populations, asymptomatic infection, hepatitis B vaccination, antiviral therapy, screening accuracy, net benefit
MeSH terms: Adolescent, Adult, Hepatitis B Surface Antigens, Hepatitis B virus, Humans, Mass Screening, Risk Factors, United States, Hepatitis B Vaccines, Hepatitis B, Chronic, Emigrants and Immigrants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks